Med-Script Regulatory Affairs Consultation and eCTD Preparation for Drug Submissions

Med-Script supports a wide range of regulatory submissions for drugs, medical devices and clinical trials, including regulatory affairs consultation and electronic common technical document (eCTD) preparation. It consists of two sister companies, Med-Script Associates and Med-Script Development.

Med-Script Associates prepares, files and supports clinical trial and drug applications, including submissions for new drugs, biologics, generics, natural health products and medical devices, while Med-Script Development is experienced in eCTD preparations for drug submissions, utilising its own fully validated eCTD software.

The companies also help ensure regulatory compliance in research and development (R&D) processes, including good manufacturing practice (GMP) evaluations, product sourcing, liaising with contract research organisations (CRO), gap analysis, pharmacovigilance reporting and planning of Phase I, II and III development.

Regulatory affairs for drug submissions

Med-Script offers comprehensive services for pharmaceutical R&D, drug submissions to national regulatory agencies, and validated eCTD preparation.

Med-Script Associates has helped pharmaceutical companies worldwide to submit successful applications for innovative drugs and biologics, as well as abbreviated new submissions for generic medications, supplements and medical devices.

eCTD preparation

Med-Script Development utilises a high-quality software that was developed in-house. The company has successfully filed numerous submissions electronically for clients, providing significant cost savings compared with other eCTD suppliers.

The specialised software has been fully validated by Health Canada, which now mandates that all drug submissions are filed electronically, according to stringent requirements.

R&D collaboration

Med-Script Associates provides R&D support by reviewing documentation generated by companies during the development phases of pharmaceuticals. The company ensures R&D activities meet the requirements of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals (ICH).

Med-Script Associates provides consulting services to guide its clients in the development of their documentation according to acceptable standards for eventual submission to the regulatory authorities. Upon request, Med-Script also prepares detailed gap analyses in order to avoid ongoing errors and to expedite the process to ensure universal regulatory acceptance.

Comprehensive regulatory services

Med-Script Associates and Med-Script Development have particular expertise and experience in the requirements of Health Canada and the Canadian Food and Drug Regulations.

Both firms collaborate extensively with companies worldwide that aim to pursue drug submissions in Canada or gain R&D advice during their early and later phases of development. The companies work closely with clients in the US, the EU, Korea and Japan.

About Med-Script 

Med-Script comprises privately owned Canadian companies that specialise in pharmaceutical regulatory affairs, R&D services and eCTD preparation.

Med-Script Associates was founded in 1972, while Med-Script Development was founded in 2014.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Address
Med-Script Associates Ltd.

Med-Script Development Inc.

176 chemin St. Henri

Ste. Marthe, Quebec

J0P 1W0

Canada

+1 450 458 2284 +1 450 977 0707 www.med-script.com

Med-Script Images

Products and Services

Video

White Papers

Related Projects



Press Release

Regional Offices

Med-Script Associates Ltd.

Med-Script Development Inc.

176 chemin St. Henri

Ste. Marthe, Quebec

J0P 1W0

Canada

+1 450 458 2284 +1 450 977 0707 www.med-script.com

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.